Mutations in this gene raise the set point for calcium homeostasis, meaning higher-than-normal serum calcium levels are required to suppress PTH release, resulting in mild to moderate hypercalcemia with normal to high PTH levels. This evidence concerns the gene PTH and hypercalcemia disease.